Effect of insulin and heparin on glucose-induced vascular damage in cell culture

Kidney International

Volumn 57, Issue 6, 2000, Pages 2492-2501

  Mandal, Anil K ^a,b,c,d   Puchalski, Jonathan T ^a,b,c   Lemley Gillespie, Susan ^a,b,c   Taylor, Catherine A ^a,b,c   Kohno, Masakazu ^a,b,c  

^a Division of Nephrology   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c KAGAWA UNIVERSITY   (Japan)

^d Medical Specialists of St Augustine   (United States)

Author keywords

Cell adhesion; D glucose; Diabetic vascular complications; Endothelial cells

Indexed keywords

ACTIN; ENDOTHELIN 1; GLUCOSE; HEPARIN; INSULIN; VIMENTIN;

ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERCELLULAR SPACE; MICROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0034036836     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00108.x     Document Type: Article

References (28)

1. 1. SANK A, WEI D, REID J: Human endothelial cells are defective in diabetic vascular disease. J Surg Res 57:647-653, 1994
2. 2. KAMOI K, ISHIBASHI M, YAMAJI T: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy. Diabetes Res Clin Pract 24:125-129, 1994
3. 3. CURCIO A, CERIFLLO A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiologic mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790, 1992
4. 4. THE DIABETES CONTROL COMPLICATIONS TRIAL RESEARCH GROUP: Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the diabetes control and complications trial. Ann Intern Med 128:517-523, 1998
5. 5. UK PROSPECTIVE DIABETICS STUDY GROUP: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 38). Lancet 352:837-853, 1998
6. 6. UK PROSPECTIVE DIABETES STUDY GROUP: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 317:703-713, 1998
7. 7. MANDAL AK, LYDEN TW, SAKLAYEN MG: Heparin lowers blood pressure: Biological and clinical perspectives. Kidney Int 47:1017-1022, 1995
8. 8. MANDAL AK, LYDEN TW, FAZEL A, SAKLAYEN MG, MEHROTRA B, MAHLING B, TAYLOR CA, YOKOKAWA K, COLVIN RB: Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxation. Kidney Int 48:1508-1516, 1995
9. 9. YOKOKAWA K, MANDAL AK, KOHNO M, HORIO T, MURAKAWA K, YASUNARI K, TAKEDA T: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol 263:R1035-R1041, 1992
10. 10. YOKOKAWA K, TAHARA H, KOHNO M, MANDAL AK, YANAGISAWA M, TAKEDA T: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 92:2080-2085, 1993
11. 11. GRAIER WF, GRUBNETHAL I, DITTRICH P, WUSCHER TC, KESTNER GM: Intracellular mechanism of high D-glucose-induced modulation of vascular proliferation. Eur J Pharmacol 294:221-229, 1995
12. 12. TAKEUCHI A, THROCKMORTON DC, BROGDEN AP, YOSHIZAWA N, RASMUSSEN H, KASHGARIAN M: Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol 268:F13-F19, 1995
13. 13. MUELLER HK, FRITSCHE U, HASLINGER A, LANDGRAF R: Glucose-filled fibronectin expression in endothelial cells is medicated by protein kinase C. Exp Clin Endocrinol Diabetes 105:32-38, 1997
14. 14. COSIO F: Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 5:1600-1609, 1995
15. 15. METSARINNE K, SAIJONMAA O, YKI-JARVINEN H, FYHRQUIST F: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism 43:878-882, 1994
16. 16. YAMAUCHI T, OHNAKA K, TAKAYANAGI R, UMEDA F, NAWATA H: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cell. FEBS Lett 267:16-18, 1990
17. 17. IMAI T, HIRATA Y, EMORI T, MARUMO F: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. Hypertension 21:353-358, 1993
18. 18. INOGUCHI T, XIA P, KUNISUKI M, HIGASHI S, FEENER EP, KING GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissue. Am J Physiol 267:E369-E379, 1994
19. 19. FERRI C, PITTONI V, PICCOLI A, LAURENTI O, CASSONS MR, BELLINIC PROPERZI G, VALESINI G, DEMATTIA G, SANTUCCI A: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vitro. J Clin Endocrinol Metab 80:829-835, 1995
20. 125I albumin. Lab Invest 47:177-184, 1982
21. 21. KANWAR YS, LINKER A, FARQUHAR MG: Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 86:688-693, 1980
22. 22. TAMSMA JT, VANDENBORN J, BRUIJIN JA, ASSINAN KJM, WEENING JJ, BERDEN JHM, WIESLANDER J, SHRAMA E, HERMANS J, VEERKAMP JH, LENKES HHPJ, VANDER WOUDE FJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
23. 23. KASINATH BS, GRELLIER P, GHOSH CHOUDHURY G, ABBOUD SL: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium. J Cell Pliysiol 167:131-136, 1996
24. 24. YOKOYAMA H, SATO K, DKUDAIRA M, MORITA C, TAKAHASHI C, SUZUKI D, SAKAI H, IWAMOTO Y: Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy. Kidney Int 56:650-658, 1999
25. 25. MYRUP B, HANSEN PM, JENSEN T, KEFOED-ENEROLDSEN A, FELDTRASMUSSEN B, GRAM J, KLUFT C, JESPERSEN J, DECKERT T: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345:421-422, 1995
26. 26. KOBAYASHI S, ISHIDA A, MORIYA TT, MORI N, FUKUDA T, TAKAMURA T: Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic change. J Lab Clin Med 133:134-143, 1999
27. 27. SUSIC D, MANDAL AK, KENTERA D: Heparin lowers blood pressure in hypertensive rats. Hypertension 4:681-685, 1982
28. 28. SUSIC D, MANDAL AK, RADJKOVIC G, VULOVIC D, KENTERA D: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats. J Lab Clin Med 111:63-72, 1988